Physician

Basel Shoua, M.D

According to 2025 Medicare claims, Basel Shoua, M.D (NPI: 1003260662) practices hematology/oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is TMC MEDICAL NETWORK (NPI: 1750832283; TIN: 811156192) and primary practice location at 85704-7891.

Shoua's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 707 traditional Medicare patients, billed 157,961 HCPCS/CPT codes, and received $2,977,559 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,578 prescription claims across 269 beneficiaries totaling $2,878,970 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 14 claims. Open Payments data shows 93 records totaling $34,947. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $11,189 to $2,878,970. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	20	23	$1,167
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	227	37,750	$655,462
2023	643	168,856	$2,878,338
2024	707	157,961	$2,977,559

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	26	261	$11,189
2020	21	53	$5,470
2021	12	20	$4,729
2022	46	137	$22,844
2023	198	1,017	$695,657
2024	269	1,578	$2,878,970

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	14	$955

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	118	402	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	221	604	$94
71260	Ct scan of chest with contrast	101	111	$93
96372	Injection of drug or substance under skin or into muscle	108	266	$10
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	119	12,195	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	42	1,099	$523,943
Revlimid	Lenalidomide	31	805	$471,791
Calquence	Acalabrutinib Maleate	24	720	$370,597
Tagrisso	Osimertinib Mesylate	11	330	$172,268
Brukinsa	Zanubrutinib	12	360	$172,182

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$955

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$34,947	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Basel Shoua, M.D?

Tedicare shows public-source Medicare data for Basel Shoua, M.D (NPI 1003260662), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Basel Shoua, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Basel Shoua, M.D?

Basel Shoua, M.D is linked to TMC MEDICAL NETWORK (billing NPI 1750832283) in the available physician profile data.

Does Basel Shoua, M.D have Open Payments data?

Basel Shoua, M.D has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.